Zobrazeno 1 - 10
of 115
pro vyhledávání: '"drug-disease interactions"'
Publikováno v:
Scandinavian Journal of Primary Health Care, Vol 38, Iss 3, Pp 330-339 (2020)
Objective Drug–disease interactions (DDSIs) are present when a drug prescribed for one disease worsens a concomitant disease. The prevalence of DDSIs in older patients in primary care is largely unknown, as well as to what extent physicians individ
Externí odkaz:
https://doaj.org/article/7de3bf8064904b94a4a0bb53ae46671c
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2022)
Caffeine is by far the most ubiquitous psychostimulant worldwide found in tea, coffee, cocoa, energy drinks, and many other beverages and food. Caffeine is almost exclusively metabolized in the liver by the cytochrome P-450 enzyme system to the main
Externí odkaz:
https://doaj.org/article/d3e01be5719f4948ad8e72951f346622
Publikováno v:
BMC Bioinformatics, Vol 20, Iss 1, Pp 1-10 (2019)
Abstract Background Predicting drug-disease interactions (DDIs) is time-consuming and expensive. Improving the accuracy of prediction results is necessary, and it is crucial to develop a novel computing technology to predict new DDIs. The existing me
Externí odkaz:
https://doaj.org/article/0e37737aee8040d7b5dcb0edf2d0a0b2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Justine M. Z. van Tongeren, S. Froukje Harkes-Idzinga, Heleen van der Sijs, Roya Atiqi, Bart J. F. van den Bemt, L. Willem Draijer, Deline Hiel, Adrian Kerremans, Bart Kremers, Marc de Leeuw, Marleen V. Olthoff, T. Kim-Loan Pham, Ricky Valentijn-Robertz, Kayan Tsoi, Iris Wichers, Maaike de Wit, Sander D. Borgsteede
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
BackgroundDrug-disease interactions negatively affect the benefit/risk ratio of drugs for specific populations. In these conditions drugs should be avoided, adjusted, or accompanied by extra monitoring. The motivation for many drug-disease interactio
Externí odkaz:
https://doaj.org/article/1da9178577724a9599534d947d8d0f4f
Publikováno v:
Journal of Family Medicine and Primary Care, Vol 7, Iss 2, Pp 414-419 (2018)
Introduction: Altered pharmacokinetics of antituberculosis (anti-TB) drugs due to interaction with non-TB medications or concomitant diseases may lead to suboptimal plasma levels of the affected drugs and hence contribute to the emergence of drug res
Externí odkaz:
https://doaj.org/article/eb2b48bfed0c47a99f85b259925b2694
Autor:
Juan Tamargo, Keld Per Kjeldsen, Eva Delpón, Anne Grete Semb, Elisabetta Cerbai, Dobromir Dobrev, Gianluigi Savarese, Patrick Sulzgruber, Giuseppe Rosano, Claudio Borghi, Sven Wassmann, Christian Tobias Torp-Pedersen, Stefan Agewall, Heinz Drexel, Iris Baumgartner, Basil Lewis, Claudio Ceconi, Juan Carlos Kaski, Alexander Niessner
Publikováno v:
Tamargo, J, Kjeldsen, K P, Delpon, E, Semb, A G, Cerbai, E, Dobrev, D, Savarese, G, Sulzgruber, P, Rosano, G, Borghi, C, Wassman, S, Torp-Pedersen, C T, Agewall, S, Drexel, H, Baumgartner, I, Lewis, B, Ceconi, C, Kaski, J C & Niessner, A 2022, ' Facing the challenge of polypharmacy when prescribing for older people with cardiovascular disease : A review by the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy ', European Heart Journal-Cardiovascular Pharmacotherapy, vol. 8, no. 4, pp. 406–419 . https://doi.org/10.1093/ehjcvp/pvac005
Tamargo, J, Kjeldsen, K P, Delpón, E, Semb, A G, Cerbai, E, Dobrev, D, Savarese, G, Sulzgruber, P, Rosano, G, Borghi, C, Wassman, S, Torp-Pedersen, C T, Agewall, S, Drexel, H, Baumgartner, I, Lewis, B, Ceconi, C, Kaski, J C & Niessner, A 2022, ' Facing the challenge of polypharmacy when prescribing for older people with cardiovascular disease. A review by the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy ', European Heart Journal-Cardiovascular Pharmacotherapy, vol. 8, no. 4, pp. 406-419 . https://doi.org/10.1093/ehjcvp/pvac005
Tamargo, J, Kjeldsen, K P, Delpón, E, Semb, A G, Cerbai, E, Dobrev, D, Savarese, G, Sulzgruber, P, Rosano, G, Borghi, C, Wassman, S, Torp-Pedersen, C T, Agewall, S, Drexel, H, Baumgartner, I, Lewis, B, Ceconi, C, Kaski, J C & Niessner, A 2022, ' Facing the challenge of polypharmacy when prescribing for older people with cardiovascular disease. A review by the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy ', European Heart Journal-Cardiovascular Pharmacotherapy, vol. 8, no. 4, pp. 406-419 . https://doi.org/10.1093/ehjcvp/pvac005
Population ageing has resulted in an increasing number of older people living with chronic diseases (multimorbidity) requiring five or more medications daily (polypharmacy). Ageing produces important changes in the cardiovascular system and represent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c7fe0ba8abe029c0e5615bee659c1df
https://doi.org/10.1093/ehjcvp/pvac005
https://doi.org/10.1093/ehjcvp/pvac005
Autor:
Sander D. Borgsteede, Katja Taxis, Maaike M E Diesveld, Pieter Cornu, Dorothea Strobach, Suzanne de Klerk
Publikováno v:
International Journal of Clinical Pharmacy, 43, 1437-1450. SPRINGER
Background Drug-disease interactions are situations where pharmacotherapy may have a negative effect on patients' comorbidities. In these cases, it can be necessary to avoid that drug, adjust its dose or monitor therapy. In the Netherlands, pharmacis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03d5bba7517b6541579fcf176ea19103
https://doi.org/10.1007/s11096-021-01308-0
https://doi.org/10.1007/s11096-021-01308-0
Autor:
Borgsteede, Sander D., Diesveld, Maaike, de Klerk, Suzanne, Cornu, Pieter, Strobach, Dorothea, Taxis, Katja
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3848::5a96dbb1456360ca9bf8450ded5421b6
https://biblio.vub.ac.be/vubir/drugdisease-interactions-in-mental-illness-clinically-relevant-alerts-for-depression-and-psychotic-disorders(40e1e212-3adf-453c-b69b-fa30cddffcbe).html
https://biblio.vub.ac.be/vubir/drugdisease-interactions-in-mental-illness-clinically-relevant-alerts-for-depression-and-psychotic-disorders(40e1e212-3adf-453c-b69b-fa30cddffcbe).html
